| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $311.1M | +1.5% |
| R&D Expense | $49.8M | -14.1% |
| SG&A Expense | $49.6M | -12.8% |
| Operating Income | -$160.9M | -130.4% |
| Pre-tax Income | -$177.3M | -156.3% |
| Income Tax | $716K | +115.0% |
| Net Income | -$178.0M | -156.1% |
| EPS (Basic) | -$2.55 | -121.7% |
| EPS (Diluted) | -$2.55 | -121.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.8M | -79.6% |
| Short-term Investments | $44.9M | -68.4% |
| Accounts Receivable | $59.1M | +3.4% |
| Current Assets | $169.3M | -63.6% |
| Total Assets | $502.6M | -41.5% |
| Current Liabilities | $89.6M | -72.5% |
| Long-term Debt | $153.3M | -59.9% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $731K | -95.0% |
| Capital Expenditures | $968K | -40.1% |
| Investing Cash Flow | $36.2M | +258.0% |
| Financing Cash Flow | -$235.8M | -255.4% |
| Free Cash Flow | -$237K | -101.8% |
| $256.9M |
| -48.0% |
| Stockholders' Equity | $245.8M | -32.7% |